South Korea's PharmaBio Companies Increase R&D Spend

---

Researched by Industrial Info Resources (Sugar Land, Texas)--South Korea's pharmaceutical and biotech companies are working to increase research and development (R&D) center investments.

According to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database, there are 13 R&D projects underway in South Korea, with a combined investment of US$616.15 million. Seven R&D centers are planned for Gyeonggi-do.

Subscribers can click here for a list of detailed project reports.

Click on the image at right for a map showing pharmaceutical and biotech R&D activity in South Korea.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 Trillion (USD).